Form 10-Q PharMerica CORP For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Pharmerica (PMC) Misses Q3 EPS by 7c; Guides FY16 Below Views
November 9, 2016 8:09 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.44, $0.07 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $512.6 million versus the consensus estimate of $530.01 million.
GUIDANCE:
Pharmerica sees FY2016 EPS of $1.84-$1.89, versus the consensus of $2.01. Pharmerica sees FY2016... More
